TaiGen Biopharmaceuticals Holdings Limited (4157)
Market Closed
15 Dec, 05:30
TWSE TWSE Primary NT$
13. 90
+1.25
+9.88%
NT$
7.18B Market Cap
- P/E Ratio
0% Div Yield
4,788,807 Volume
- Eps
NT$ 12.65
Previous Close Day Range
13.9 13.9
Year Range
7.44 13.9
Want to track 4157 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| 4157 TaiGen Biopharmaceuticals Holdings Limited 11 Nov 2025 | | - | - |
| 4157 TaiGen Biopharmaceuticals Holdings Limited 27 Aug 2025 | | - | - |
4157 Earnings Reports FAQ
What is the earnings per share (EPS) for 4157?
EPS data for 4157 is currently not available, as TaiGen Biopharmaceuticals Holdings Limited has not reported recent earnings.
What is the company's earnings growth rate?
TaiGen Biopharmaceuticals Holdings Limited has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
TaiGen Biopharmaceuticals Holdings Limited has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for TaiGen Biopharmaceuticals Holdings Limited are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 4157 at this time, as TaiGen Biopharmaceuticals Holdings Limited has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
